Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

ClinicalTrials.gov ID: NCT00161681

Public ClinicalTrials.gov record NCT00161681. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 9:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Levonorgestrel 90 Mcg and Ethinyl Estradiol 20 Mcg in a Continuous Daily Regimen on Menstrual Cycle-Related Symptoms

Study identification

NCT ID
NCT00161681
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • Levonorgestrel/Ethinyl Estradiol Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2005
Primary completion
Jul 31, 2006
Completion
Jul 31, 2006
Last update posted
Feb 7, 2013

2005 – 2006

United States locations

U.S. sites
48
U.S. states
23
U.S. cities
43
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801
Not listed Peoria Arizona 85381
Not listed Phoenix Arizona 85031
Not listed Phoenix Arizona 85032
Not listed Tucson Arizona 85715
Not listed San Diego California 92103
Not listed Denver Colorado 80202
Not listed Longmont Colorado 80501
Not listed Aventura Florida 33180
Not listed Boynton Beach Florida 33437
Not listed Clearwater Florida 33761
Not listed DeLand Florida 32720
Not listed Fort Myers Florida 33916
Not listed Miami Florida 33143
Not listed Miami Florida 33186
Not listed Pembroke Pines Florida 33024
Not listed Tampa Florida 33607
Not listed West Palm Beach Florida 33407
Not listed Atlanta Georgia 30328
Not listed Atlanta Georgia 30342
Not listed Savannah Georgia 31406
Not listed Idaho Falls Idaho 83404
Not listed Chicago Illinois 60612
Not listed Chicago Illinois 60631
Not listed Lexington Kentucky 40509
Not listed Kansas City Missouri 64114
Not listed Las Vegas Nevada 89109
Not listed Las Vegas Nevada 89118
Not listed Moorestown New Jersey 08057
Not listed Rochester New York 14609
Not listed Fayetteville North Carolina 28304
Not listed Winston-Salem North Carolina 27103
Not listed Cleveland Ohio 44122
Not listed Mogadore Ohio 44260
Not listed Eugene Oregon 97401
Not listed Medford Oregon 97504
Not listed Philadelphia Pennsylvania 19104
Not listed Pittsburgh Pennsylvania 15206
Not listed Wexford Pennsylvania 15090
Not listed Hilton Head Island South Carolina 29926
Not listed Mt. Pleasant South Carolina 29464
Not listed Nashville Tennessee 37203
Not listed Houston Texas 77024
Not listed San Antonio Texas 78229
Not listed Sandy City Utah 84070
Not listed Richmond Virginia 23226
Not listed Lakewood Washington 98499
Not listed Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00161681, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 7, 2013 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00161681 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →